RNA binding proteins in MLL-rearranged leukemia.

"Declarations Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interestsD.S.R is a consultant for AbbVie Inc., providing educational lectures related to clinical work in hematologic malignancies. Competing interests D.S.R is a consultant for AbbVie Inc., providing educational lectures related to clinical work in hematologic malignancies."

"Funding The authors acknowledge research funding from the Tumor Cell Biology Training Grant NIH T32 CA009056 (T.M.T.), NIH/NCI R01 CA166450 and R01CA264986 (D.S.R.), NIH/NCI R21 CA197441 (D.S.R.), American Society of Hematology Bridge Grant (D.S.R.), UCLA Jonsson Comprehensive Cancer Center Seed Grant (D.S.R.) and STOPCancer/Barbara and Gary Luboff Mitzvah Fund Seed Grant (D.S.R.)."